aap Sales Decline on U.S. Distribution Loss
aap Implantate's revenue decline in 3Q19 was attributed to the termination of a distributor sales relationship in the U.S. Nov 14, 2019
Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants
Medicrea's 3Q19 growth was due to growth in key markets like the U.S. and Belgium, in addition to continuing uptake of their patient-specific rods. Nov 14, 2019
OrthoPediatrics Records Highest Revenue Quarter in Company History
OrthoPediatrics recorded its highest ever revenue for a quarter in 3Q19 on the strength of new product introductions and an expanded sales force. Nov 11, 2019
Xtant Taps New CEO to Lead Turnaround Effort
Xtant Medical’s revenue continued to decline in 3Q19 as the company selected Sean Browne as the new President and CEO to lead a turnaround. Nov 11, 2019
DJO Joint Replacement Growth Driven by New Products
DJO’s joint replacement business grew in the high single digits, a trend leadership expects to be able to sustain on a consistent basis. Nov 11, 2019
Seikagaku Grows in Low Double-Digits on Favorable U.S. Reimbursement Status
Seikagaku grew in the low double-digits in their fiscal year 2Q19 on favorable reimbursement decisions from U.S. insurers and increased volumes. Nov 08, 2019
Vericel to Expand MACI Salesforce Again on Strong Demand
Vericel’s 3Q19 grow was attributable to continued strong demand for MACI, and the company expects to maintain double-digit growth in the years ahead. Nov 07, 2019
Globus Medical Double-Digit Growth Driven by Spinal Hardware and ExcelsiusGPS
Globus Medical’s 3Q19 double-digit revenue growth was driven by significant share gains and the continuing success of its ExcelsiusGPS platform. Nov 07, 2019
Zimmer Biomet Gains Momentum on ROSA Knee and Increased Supply
Zimmer Biomet saw solid execution and revenue growth across most of their orthopedic business in 3Q19, driven by an increasingly stable supply chain. Nov 06, 2019
RTI Surgical Reduces Guidance Due to Softer than Expected coflex Sales
RTI Surgical’s integration of Paradigm progressed slower than expected in 3Q19, leading to softer sales of coflex and a 2019 revenue guidance reduction. Nov 05, 2019
